Michael W. Bonney, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 11,836 shares at $185.99 ($2.2M) on 2023-08-03, disclosed to the SEC on 2023-08-04.
Open-market sale of $2.2M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $181.08 | 300 | $54K | 2.5% |
| 2 | $181.08 | 300 | $54K | 2.5% |
| 3 | $182.45 | 500 | $91K | 4.2% |
| 4 | $183.75 | 560 | $103K | 4.7% |
| 5 | $184.89 | 1,535 | $284K | 12.9% |
| 6 | $184.89 | 1,535 |
| $284K |
| 12.9% |
| 7 | $185.99 | 1,714 | $319K | 14.5% |
| 8 | $185.99 | 1,714 | $319K | 14.5% |
| 9 | $187.04 | 1,389 | $260K | 11.8% |
| 10 | $187.04 | 1,389 | $260K | 11.8% |
| 11 | $187.71 | 450 | $84K | 3.8% |
| 12 | $187.71 | 450 | $84K | 3.8% |
| Total | $185.58 avg | 11,836 | $2.2M | 100% |
| Filing → |
| ALNY | SELL | 2023-12-29 | $5.8M | — | Filing → |
| BMY | BUY | 2020-06-09 | $5K | — | Filing → |
| SRPT | BUY | 2019-09-09 | $173K | — | Filing → |